Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Historical Holders from Q1 2018 to Q3 2025

Symbol: CDLX on Nasdaq
Type / Class: Equity / Common Stock, par value $0.0001
Shares outstanding: 53,041,500
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 22,756,684
Holdings value: $55,312,585
% of all portfolios: 0%
Number of holders: 80
Number of buys: 39
Number of sells: -53
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
CAS Investment Partners, LLC	9.8%	-11%	$10,656,037	-$854,463	5,198,067	-7.4%	CAS Investment Partners, LLC	19 Aug 2025
VANGUARD GROUP INC	4.6%		$3,975,815		2,416,909		The Vanguard Group	30 Jun 2025
BlackRock, Inc.	2.1%		$1,810,565		1,098,977		BlackRock, Inc.	30 Jun 2025

Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	22,756,684	$55,312,585	-$1,238,648	$2,215,020	$4,055,190	$2.43	80
2025 Q2	24,551,816	$40,388,162	-$6,876,388	$648,126	$483,524	$1.64	87
2025 Q1	28,581,930	$52,019,284	-$5,385,568	$898,065	$512,876	$1.82	104
2024 Q4	30,318,387	$112,466,107	-$2,088,576	$976,472	$1,887,843	$3.71	105
2024 Q3	30,794,820	$98,563,618	-$20,795,943	$2,480,328	$3,931,928	$3.2	109
2024 Q2	33,695,414	$276,632,711	-$28,175,400	$8,278,143	$7,769,123	$8.21	123
2024 Q1	35,620,190	$516,145,298	+$96,938,383	$18,719,631	$10,709,559	$14.49	141
2023 Q4	29,212,104	$269,093,210	+$5,557,027	$9,839,964	$4,736,703	$9.21	122
2023 Q3	28,041,297	$463,142,226	+$17,744,620	$12,030,150	$12,769,350	$16.5	111
2023 Q2	27,412,381	$173,379,558	-$8,554,891	$2,172,824	$605,456	$6.32	107
2023 Q1	28,654,397	$97,285,032	-$6,579,840	$1,180,927	$500,131	$3.4	100
2022 Q4	29,783,293	$172,154,817	-$28,548,438	$3,213,102	$1,696,244	$5.78	120
2022 Q3	31,554,421	$296,615,241	-$30,189,534	$13,497,000	$3,065,000	$9.4	119
2022 Q2	31,596,179	$705,114,664	-$47,941,923	$2,148,000	$2,262,000	$22.31	129
2022 Q1	33,306,573	$1,831,644,508	+$20,984,402	$24,338,000	$6,838,712	$54.98	148
2021 Q4	32,869,535	$2,172,578,259	+$79,885,779	$35,840,000	$10,899,000	$66.09	156
2021 Q3	31,254,515	$2,624,187,470	-$77,766,844	$38,340,552	$16,619,918	$83.94	162
2021 Q2	31,402,934	$3,990,653,437	+$126,270,154	$10,763,000	$14,965,000	$126.93	189
2021 Q1	29,846,728	$3,274,240,688	+$271,523,652	$9,883,000	$8,820,000	$109.7	199
2020 Q4	27,784,592	$3,965,954,154	+$70,956,802	$43,742,000	$30,588,000	$142.77	194
2020 Q3	26,692,394	$1,883,241,294	+$112,252,889	$5,343,000	$11,800,000	$70.57	162
2020 Q2	25,018,920	$1,750,601,005	+$226,035,991	$6,694,000	$14,614,000	$69.98	164
2020 Q1	22,440,998	$784,589,581	-$47,809,544	$3,062,000	$3,602,000	$34.96	141
2019 Q4	23,008,936	$1,446,322,852	+$109,382,347	$2,546,000	$1,299,000	$62.86	154
2019 Q3	21,246,669	$712,189,095	+$88,173,279			$33.52	117
2019 Q2	19,154,562	$497,359,320	+$81,154,271			$25.98	79
2019 Q1	16,284,415	$269,598,973	+$7,820,714			$16.54	62
2018 Q4	16,111,197	$174,481,975	+$5,332,809			$10.83	61
2018 Q3	11,931,477	$298,164,482	+$47,426,352			$25.04	59
2018 Q2	10,063,300	$217,430,809	+$11,913,905			$21.76	52
2018 Q1	9,791,394	$141,747,708	+$141,747,708			$14.63	51